These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8072869)

  • 1. [MR imaging oral contrast agent mixed with milk for the small intestine].
    Hirohashi S; Hirohashi R; Uchida H; Kitano S; Tanaka M; Matsuo N; Ohishi H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):784-8. PubMed ID: 8072869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Optimization of dosage and exam technique in the use of oral contrast media in magnetic resonance].
    Broglia L; Tortora A; Maccioni F; Arpesani R; Marcelli G; Ascarelli A; Rossi P
    Radiol Med; 1999 May; 97(5):365-70. PubMed ID: 10432968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical efficacy of suppression and visualization of the duodenal fluid in MR cholangiopancreatography using ferric ammonium citrate].
    Takahara T; Kurihara Y; Takahashi M; Nakajima Y; Ishikawa T
    Nihon Rinsho; 1998 Nov; 56(11):2865-9. PubMed ID: 9847611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of high concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent: application in MR cholangiography].
    Takahara T; Saeki M; Nosaka S; Shimoyamada K; Suemitsu I; Nakajima Y; Yoshikawa T; Ishikawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Aug; 55(9):697-9. PubMed ID: 7478957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
    Patten RM; Lo SK; Phillips JJ; Bowman SC; Glazer GM; Wall SD; Bova JG; Harris RD; Wheat RL; Johnson CD
    Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent].
    Takahara T; Yoshikawa T; Saeki M; Nosaka S; Shimoyamada K; Nakajima Y; Ishikawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):425-6. PubMed ID: 7617470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI.
    Hirohashi S; Uchida H; Yoshikawa K; Fujita N; Ohtomo K; Yuasa Y; Kawamura Y; Matsui O
    Magn Reson Imaging; 1994; 12(6):837-46. PubMed ID: 7968283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MR imaging of colonic cancer with retrograde administration of contrast material containing ferric ammonium citrate].
    Mizuguchi M; Matsuo Y; Fukahori T; Kudo S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Dec; 55(15):1063-5. PubMed ID: 8587850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract.
    Babos M; Schwarcz A; Randhawa MS; Marton B; Kardos L; Palkó A
    Eur J Radiol; 2008 Jan; 65(1):133-9. PubMed ID: 17485189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New development of cellulose-ferric ammonium citrate solution as a contrast-enhancement agent for magnetic resonance imaging of esophageal diseases].
    Ogawa Y; Noda Y; Sawada A; Fujiwara Y; Hamada N; Terashima M; Inomata T; Yoshida S; Morio K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Oct; 54(12):1178-80. PubMed ID: 9261198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-contrast magnetic resonance imaging of the small and large bowel: effectiveness in the evaluation of inflammatory bowel disease.
    Maccioni F
    Abdom Imaging; 2010 Feb; 35(1):31-40. PubMed ID: 19082651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral ferric ammonium citrate solution in MRCP for diagnosing low-level obstructive jaundice].
    Yang P; Zhang YD; Li NF; Li WZ; Zhou GF
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):347-50. PubMed ID: 17478951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium sulfate as an oral contrast medium in magnetic resonance imaging of the small intestine.
    Shi H; Liu C; Ding HY; Li CW
    Eur J Radiol; 2012 Mar; 81(3):e370-5. PubMed ID: 22197089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease.
    Laghi A; Paolantonio P; Iafrate F; Borrelli O; Dito L; Tomei E; Cucchiara S; Passariello R
    Radiol Med; 2003; 106(1-2):18-27. PubMed ID: 12951547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Elimination of artifacts in MRCP: technical consideration].
    Ohgi K; Satoh K; Tanaka S; Higami T; Furukawa T; Akiyama H; Kimura S; Uehara K; Murata K; Higashi M
    Nihon Rinsho; 1998 Nov; 56(11):2854-8. PubMed ID: 9847609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal contrast agents for MR imaging.
    Brown JJ
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):25-35. PubMed ID: 8673714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR enteroclysis using iron oxide particles (ferristene) as an endoluminal contrast agent: an open phase III trial.
    Boraschi P; Braccini G; Gigoni R; Cartei F; Perri G
    Magn Reson Imaging; 2004 Oct; 22(8):1085-95. PubMed ID: 15527995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging of the small bowel in Crohn's disease.
    Frøkjaer JB; Larsen E; Steffensen E; Nielsen AH; Drewes AM
    Scand J Gastroenterol; 2005 Jul; 40(7):832-42. PubMed ID: 16109660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen. Safety and diagnostic efficacy.
    Kivelitz D; Gehl HB; Heuck A; Krahe T; Taupitz M; Lodemann KP; Hamm B
    Acta Radiol; 1999 Jul; 40(4):429-35. PubMed ID: 10394873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.